Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-line Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07662395
What this trial is testing

SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer

Who this might be right for
Double Blind
Sinocelltech Ltd. 410
Testing effectiveness (Phase 2)Looking for participantsNCT05978193
What this trial is testing

Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaEsophageal CancerMetastatic Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital 100
Large-scale testing (Phase 3)Looking for participantsNCT07318558
What this trial is testing

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

Who this might be right for
Ovarian NeoplasmsOvarian Cancer
Merck Sharp & Dohme LLC 900
Post-approval studies (Phase 4)Not Yet RecruitingNCT07567313
What this trial is testing

Stage IV Lung Squamous Cell Carcinoma Treated With or Without Bronchial Artery Chemoembolization After First-line Chemotherapy and Immunotherapy

Who this might be right for
Lung Squamous Cell Carcinoma Stage IV
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 166
Testing effectiveness (Phase 2)Study completedNCT04271813
What this trial is testing

Anlotinib Plus Sintilimab as First-line Treatment for Patients With Advanced Colorectal Cancer (APICAL-CRC)

Who this might be right for
Colorectal CancerImmunotherapyAnlotinib+3 more
Shanghai Changzheng Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06306560
What this trial is testing

Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Harbin Medical University 40
Testing effectiveness (Phase 2)UnknownNCT00974324
What this trial is testing

Endostar Combined With CHOP Regimen as First Line Chemotherapy for Peripheral T Cell Lymphoma

Who this might be right for
T Cell Lymphoma
Fudan University 15
Not applicableLooking for participantsNCT07061379
What this trial is testing

Patient Reported Outcome Measurements (PROMs) Impact on Clinical Outcome in firsT Line settIng Non- Small-Cell Lung Cancer (NSCLC) According to Chemo- Immunotherapy reGimen

Who this might be right for
PROMs
IRCCS San Raffaele 144
Not applicableActive Not RecruitingNCT07024862
What this trial is testing

Long-term Outcomes Among Patients With Programmed Death-ligand 1 <1% Metastatic Non-small Cell Lung Cancer Treated With First-line Nivolumab + Ipilimumab + 2 Cycles of Chemotherapy

Who this might be right for
Metastatic Non-small Cell Lung Cancer
Bristol-Myers Squibb 100
Large-scale testing (Phase 3)UnknownNCT03668496
What this trial is testing

SHR-1210 in Combination With Carboplatin + Paclitaxel in Subjects With Squamous NSCLC

Who this might be right for
Lung Cancer Squamous CellLung Cancer Stage IVPD-1 Antibody+1 more
Jiangsu HengRui Medicine Co., Ltd. 390
Testing effectiveness (Phase 2)Study completedNCT02337946
What this trial is testing

Safety and Efficacy Study of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Participants With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal Carcinoma

Who this might be right for
Colorectal Carcinoma
Takeda 164
Testing effectiveness (Phase 2)Ended earlyNCT03490760
What this trial is testing

Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the Pancreas

Who this might be right for
Adenocarcinoma of the Pancreas
Baptist Health South Florida 9
Not applicableUnknownNCT04654403
What this trial is testing

Study of First-line Camrelizumab With or Without Chemotherapy for Advanced Esophageal Squamous Cell Cancer

Who this might be right for
Esophageal Cancer
The First Affiliated Hospital of Zhengzhou University 337
Large-scale testing (Phase 3)Study completedNCT00320359
What this trial is testing

Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer

Who this might be right for
Lung Cancer, Small Cell
GlaxoSmithKline 700
Post-approval studies (Phase 4)UnknownNCT03755869
What this trial is testing

Study of Anlotinib in Non-squamous NSCLC Patients Who Failed First-Line（ALTER-L020）

Who this might be right for
Non-squamous NSCLC
First Affiliated Hospital Xi'an Jiaotong University 103
Testing effectiveness (Phase 2)Active Not RecruitingNCT03620669
What this trial is testing

1st Line Durvalumab in PS 2 NSCLC Patients

Who this might be right for
NSCLC Stage IVNSCLC Stage IIIB
Swiss Cancer Institute 48
Testing effectiveness (Phase 2)Study completedNCT05864105
What this trial is testing

PM8002 in Combination With Chemotherapy as First Line Therapy in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Biotheus Inc. 35
Testing effectiveness (Phase 2)Study completedNCT01912053
What this trial is testing

Efficacy Study of Intra-hepatic Administration of Therasphere® in Association With Intravenous Chemotherapy to Treat Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Center Eugene Marquis 41
Testing effectiveness (Phase 2)UnknownNCT01757366
What this trial is testing

Safety and Efficacy of Ginsenoside Rg3 in Combination With First-line Chemotherapy in Advanced Gastric Cancer

Who this might be right for
Self Efficacy
Hebei Tumor Hospital 100
Testing effectiveness (Phase 2)Study completedNCT04205630
What this trial is testing

SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma

Who this might be right for
Endometrial Cancer
Byondis B.V. 64
Next Page